Study Using the ShiraTronics Migraine Therapy System
Unknown statusNot applicableNCT05700318
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this pilot study is to assess the preliminary safety and efficacy of the ShiraTronics Migraine Therapy System in prophylactic treatment of patients with refractory chronic migraine.
Study details
- Official title
- A Pilot Study Assessing Preliminary Safety and Efficacy of The ShiraTronics Migraine Therapy System in Relieving, Interrupting, and Preventing Chronic Migraine
- Conditions
- Interventions
- Device: neurostimulator
- Sponsor
- ShiraTronics
- Start date
- 2023-05-05
- Primary completion
- 2025-03
- Sex
- All
- Age range
- from 22 Years
- Results posted
- No results posted in this snapshot
- Countries
- Australia
- Total sites listed
- 4
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Participants who are 22 years of age or older. 2. History of migraine ≥ 12 months. 3. Participants experiencing between 15 to 26 headache days per month, with at least 8 headache days (per month) with migraine phenotype presentation. 4. Inadequate response to, unwilling, or contraindicated to Onabotulinumtoxin A and CGRP monoclonal antibodies therapy. 5. Stable use of migraine medication. Exclusion Criteria: 1. Post-traumatic headache. 2. Medication overuse headache. 3. New daily persistent headache. 4. Report experiencing unremitting, continuous headaches with no relief. 5. Previously implanted neurostimulator to treat headache. 6. History of cervical radiofrequency ablation or had any other intervention/device for migraine.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05700318